NCT00334893: Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer |
|
|
| Completed | 2 | 74 | US | eribulin mesylate, B1939, E7389, ER-086526, halichrondrin B analog | National Cancer Institute (NCI) | Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer | 03/12 | 03/12 | | |
